You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK4428859A

Showing 1 - 25 of 4,060
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Dallas, San Antonio, Toronto (GSK4381562, Dostarlimab)

Recruiting
  • Neoplasms
  • Philadelphia, Pennsylvania
  • +4 more
Nov 18, 2022

Tumors Trial in Worldwide (GSK6097608, Dostarlimab, GSK4428859A (EOS884448))

Recruiting
  • Neoplasms
  • Los Angeles, California
  • +9 more
Aug 26, 2022

Lung Cancer, Non-Small Cell Trial in Worldwide (Pembrolizumab, Dostarlimab, GSK4428859A)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
  • +14 more
Dec 26, 2022

Multiple Myeloma Trial in Belgium, France, United States (EOS884448, Iberdomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Hackensack, New Jersey
  • +3 more
Jun 15, 2022

Advanced Cancer, Lung Cancer, Head Neck Cancer Trial in Belgium, France, United States (EOS-448, pembrolizumab, inupadenant)

Recruiting
  • Advanced Cancer
  • +3 more
  • Bergen, New Jersey
  • +3 more
Jun 13, 2022

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Respiratory Syncytial Virus Infections Trial in Worldwide (RSVPreF3 OA Investigational Vaccine)

Not yet recruiting
  • Respiratory Syncytial Virus Infections
  • RSVPreF3 OA Investigational Vaccine
  • Phoenix, Arizona
  • +52 more
Jun 16, 2023

HIV Trial in Worldwide (VH3739937, Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +18 more
Sep 22, 2023

HIV Trial in Puerto Rico, United States (VH3810109, Cabotegravir, Standard of care (SOC))

Not yet recruiting
  • HIV Infections
  • VH3810109
  • +3 more
  • Birmingham, Alabama
  • +42 more
Aug 9, 2023

Tumors Trial in United States (GSK4524101, Niraparib)

Not yet recruiting
  • Neoplasms
  • San Francisco, California
  • +5 more
Oct 5, 2023

Tumors, Head and Neck Trial in Worldwide (Dostarlimab, Belrestotug, GSK6097608)

Not yet recruiting
  • Neoplasms, Head and Neck
  • New Haven, Connecticut
  • +121 more
Oct 3, 2023

HIV Trial in Worldwide (VH4004280, VH4011499, VH4004280 Matching Placebo)

Not yet recruiting
  • HIV Infections
  • Bakersfield, California
  • +42 more
Sep 12, 2023

Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir Injectable Suspension, Rilpivirine Injectable

Completed
  • Human Immunodeficiency Virus Type 1 (HIV-1)
  • Cabotegravir Injectable Suspension
  • Rilpivirine Injectable Suspension
  • Bakersfield, California
  • +31 more
May 31, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • San Diego, California
  • +99 more
Oct 6, 2023

Gastroenteritis Trial in China (GSK's liquid oral live attenuated HRV, PCV-free liquid formulation of GSK's oral live attenuated

Recruiting
  • Gastroenteritis
  • GSK's liquid oral live attenuated HRV
  • PCV-free liquid formulation of GSK's oral live attenuated HRV
  • Chengdu, Sichuan, China
  • +7 more
Sep 7, 2023

Meningitis, Meningococcal Trial in Korea, Republic of (rMenB+OMV NZ)

Not yet recruiting
  • Meningitis, Meningococcal
  • rMenB+OMV NZ
  • Anyang-Si, Gyeonggi-do, Korea, Republic of
  • +6 more
Oct 27, 2023

Colitis, Ulcerative Trial in Cambridge (GSK4381406, Placebo, Indomethacin)

Not yet recruiting
  • Colitis, Ulcerative
  • Cambridge, United Kingdom
    GSK Investigational Site
Aug 11, 2023

Chickenpox Trial in United States (Investigational varicella vaccine low potency, Investigational varicella vaccine medium

Recruiting
  • Chickenpox
  • Investigational varicella vaccine low potency
  • +7 more
  • Bryant, Arkansas
  • +49 more
Jan 24, 2023

Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

Active, not recruiting
Has Results
  • Infection, Human Immunodeficiency Virus
  • HIV Infections
  • Birmingham, Alabama
  • +49 more
Dec 26, 2022

Tumors Trial in Worldwide (Letetresgene autoleucel)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel
  • Pittsburgh, Pennsylvania
  • +5 more
Aug 7, 2023

Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

Recruiting
  • Hepatitis B, Chronic
  • Edegem, Belgium
  • +47 more
Jan 24, 2023

Influenza, Human Trial in Gent, Wilrijk (GSK4382276A Dose level 1, GSK4382276A Dose level 2, GSK4382276A Dose level 3)

Active, not recruiting
  • Influenza, Human
  • GSK4382276A Dose level 1
  • +4 more
  • Edegem, Belgium
  • +6 more
Jan 9, 2023

HIV Trial in Worldwide (Cabotegravir Tablets, Cabotegravir Injectable Suspension (CAB LA), Rilpivirine Tablets)

Active, not recruiting
  • HIV Infections
  • Cabotegravir Tablets
  • +4 more
  • Bakersfield, California
  • +116 more
Jan 22, 2023

Diphtheria Trial in Schoenau Am Koenigssee, Milano, Santiago de Compostela (DTPa-HBV-IPV/Hib, DTaP5-HBV-IPV-Hib, Pneumococcal

Completed
  • Diphtheria
  • DTPa-HBV-IPV/Hib
  • +2 more
  • Rosenheim, Bayern, Germany
  • +19 more
Jan 24, 2023